Local delivery of allogeneic bone marrow and adipose tissue-derived mesenchymal stromal cells for cutaneous wound healing in a porcine model

Journal of Tissue Engineering and Regenerative Medicine

Volumn 10, Issue 2, 2016, Pages E90-E100

  Hanson, Summer E ^a,c   Kleinbeck, Kyle R ^b   Cantu, David ^b   Kim, Jaeyhup ^a   Bentz, Michael L ^a   Faucher, Lee D ^a   Kao, W John ^a,b,c   Hematti, Peiman ^a,d  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c University of Wisconsin Madison   (United States)

^d UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Cell based therapy; Cutaneous wounds; Mesenchymal stromal stem cells; Tissue regeneration

Indexed keywords

ANIMALS; BONE; CELL CULTURE; CELLS; FLOWCHARTING; POLYMERASE CHAIN REACTION;

ADIPOSE TISSUE; ALLOGENEIC BONE MARROW; BONE MARROW; CELL-BASED THERAPY; CELL-BE; CELL/B.E; CUTANEOUS WOUNDS; MARROW TISSUE; MESENCHYMAL STROMAL/STEM CELL; STROMAL STEM CELLS;

TISSUE REGENERATION;

DNA;

ADIPOSE TISSUE DERIVED MESENCHYMAL STROMAL CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL MATURATION; CELL STRUCTURE; CONTROLLED STUDY; DNA DETERMINATION; EPIDERMIS; EPITHELIZATION; FEMALE; GAUZE DRESSING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MALE; MESENCHYMAL STROMA CELL; NONHUMAN; PRIORITY JOURNAL; SAFETY; SKIN INJURY; WOUND HEALING; ADIPOSE TISSUE; ALLOTRANSPLANTATION; ANIMAL; BONE MARROW CELL; CELL DIFFERENTIATION; CYTOLOGY; DISEASE MODEL; MESENCHYMAL STEM CELL TRANSPLANTATION; MINIPIG; PATHOLOGY; PIG; POLYMERASE CHAIN REACTION; SKIN; TIME FACTOR;

ADIPOSE TISSUE; ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; EPIDERMIS; FEMALE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; POLYMERASE CHAIN REACTION; SKIN; SUS SCROFA; SWINE; SWINE, MINIATURE; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; WOUND HEALING;

EID: 84957838812     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1700     Document Type: Article

References (46)

1. Agay D, Scherthan H, Forcheron F et al. 2010; Multipotent mesenchymal stem cell grafting to treat cutaneous radiation syndrome: development of a new minipig model. Exp Hematol 38(10): 945-956
2. Badiavas EV, Falanga V. 2003; Treatment of chronic wounds with bone marrow-derived cells. Arch Dermatol 139: 510-516.
3. Battiwalla M, Hematti P. 2009; Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy 11: 503-515.
4. Beahm EK, Walton RL, Patrick CW Jr. 2003; Progress in adipose tissue construct development. Clin Plast Surg 30:(547) 58, viii.
5. Beausang E, Floyd H, Dunn KW et al. 1998; A new quantitative scale for clinical scar assessment. Plast Reconstr Surg 102: 1954-1961.
6. Blanton MW, Hadad I, Johnstone BH et al. 2009; Adipose stromal cells and platelet-rich plasma therapies synergistically increase revascularization during wound healing. Plast Reconstr Surg 123: 56S-64S.
7. Bradley JA, Bolton EM, Pedersen RA. 2002; Stem cell medicine encounters the immune system. Nat Rev Immunol 2: 859-871.
8. Caplan AI. 2007; Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213: 341-347.
9. da Silva Meirelles L, Chagastelles PC, Nardi NB. 2006; Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119: 2204-2213.
10. Dame MK, Paruchuri T, DaSilva M et al. 2009; The Gottingen Minipig for assessment of retinoid efficacy in the skin: comparison of results from topically treated animals with results from organ-cultured skin. In Vitro Cell Dev Biol Anim 45: 551-557.
11. Dame MK, Spahlinger DM, DaSilva M et al. 2008; Establishment and characteristics of Gottingen Minipig skin in organ culture and monolayer cell culture: relevance to drug safety testing. In Vitro Cell Dev Biol Anim 44: 245-252.
12. Dominici M, Le Blanc K, Mueller I et al. 2006; Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
13. Falanga V, Iwamoto S, Chartier M et al. 2007; Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng 13: 1299-1312.
14. Faucher LD, Kleinbeck KR, Kao WJ. 2010; Multifunctional photopolymerized semi-interpenetrating network (sIPN) system containing bupivacaine and silver sulfadiazine is an effective donor site treatment in a swine model. J Burn Care Res 31: 137-145.
15. Gimble JM, Bunnell BA, Guilak F. 2012; Human adipose-derived cells: an update on the transition to clinical translation. Regen Med 7: 225-235.
16. Hanson S, Thibeault SL, Hematti P. 2010a; Clinical applications of mesenchymal stem cells in laryngotracheal reconstruction. Curr Stem Cell Res Ther 5: 268-272.
17. Hanson SE, Bentz ML, Hematti P. 2010b; Mesenchymal stem cell therapy for non-healing cutaneous wounds. Plast Reconstr Surg 125: 510-516.
18. Hanson SE, Kim J, Johnson BH et al. 2010c; Characterization of mesenchymal stem cells from human vocal fold fibroblasts. Laryngoscope 120: 546-551.
19. Herdrich BJ, Lind RC, Liechty KW. 2008; Multipotent adult progenitor cells: their role in wound healing and the treatment of dermal wounds. Cytotherapy 10: 543-550.
20. Johansen T, Hansen HS, Richelsen B et al. 2001; The obese Gottingen Minipig as a model of the metabolic syndrome: dietary effects on obesity, insulin sensitivity, and growth hormone profile. Comp Med 51: 150-155.
21. Kim J, Hematti P. 2009; Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol 37: 1445-1453.
22. Kleinbeck KR, Faucher L, Kao WJ. 2009; Multifunctional in situ photopolymerized semi-interpenetrating network system is an effective donor site dressing: a cross comparison study in a swine model. J Burn Care Res 30: 37-45.
23. Kleinbeck KR, Faucher LD, Kao WJ. 2010; Biomaterials modulate interleukin-8 and other inflammatory proteins during re-epithelialization in cutaneous partial-thickness wounds in pigs. Wound Repair Regen 18: 486-498.
24. Larsen MO, Juhl CB, Porksen N et al. 2005; Beta-cell function and islet morphology in normal, obese, and obese beta-cell mass-reduced Gottingen Minipigs. Am J Physiol Endocrinol Metab 288: E412-421.
25. Laurila JP, Laatikainen L, Castellone MD et al. 2009; Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury model. Cytotherapy 11: 726-737.
26. Le Blanc K, Ringden O. 2007; Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 262: 509-525.
27. Le Blanc K, Samuelsson H, Gustafsson B et al. 2007; Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia 21: 1733-1738.
28. Markert M, Stubhan M, Mayer K et al. 2009; Validation of the normal, freely moving Gottingen Minipig for pharmacological safety testing. J Pharmacol Toxicol Methods 60: 79-87.
29. Martin P. 1997; Wound healing--aiming for perfect skin regeneration. Science 276: 75-81.
30. Menke NB, Ward KR, Witten TM et al. 2007; Impaired wound healing. Clin Dermatol 25: 19-25.
31. Mustoe TA, O'Shaughnessy K, Kloeters O. 2006; Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis. Plast Reconstr Surg 117: 35S-41S.
32. Nauta AJ, Fibbe WE. 2007; Immunomodulatory properties of mesenchymal stromal cells. Blood 110: 3499-3506.
33. Noel D, Caton D, Roche S et al. 2008; Cell specific differences between human adipose-derived and mesenchymal stromal cells despite similar differentiation potentials. Exp Cell Res 314: 1575-1584.
34. Ogawa R. 2010; The most current algorithms for the treatment and prevention of hypertrophic scars and keloids. Plast Reconstr Surg 125: 557-568.
35. Panuncialman J, Falanga V. 2007; The science of wound bed preparation. Clin Plast Surg 34: 621-632.
36. Prockop DJ. 2009; Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms. Mol Ther 17: 939-946.
37. Qvist MH, Hoeck U, Kreilgaard B et al. 2000; Evaluation of Gottingen Minipig skin for transdermal in vitro permeation studies. Eur J Pharm Sci 11: 59-68.
38. Rubes J, Vozdova M, Kubickova S. 1999; Aneuploidy in pig sperm: multicolor fluorescence in situ hybridization using probes for chromosomes 1, 10, and Y. Cytogenet Cell Genet 85: 200-204.
39. Stappenbeck TS, Miyoshi H. 2009; The role of stromal stem cells in tissue regeneration and wound repair. Science 324: 1666-1669.
40. Sullivan T, Smith J, Kermode J et al. 1990; Rating the burn scar. J Burn Care Rehabil 11: 256-260.
41. Sullivan TP, Eaglstein WH, Davis SC et al. 2001; The pig as a model for human wound healing. Wound Repair Regen 9: 66-76.
42. Uccelli A, Pistoia V, Moretta L. 2007; Mesenchymal stem cells: a new strategy for immunosuppression? Trends Immunol 28: 219-226.
43. Vande Berg JS, Robson MC. 2003; Arresting cell cycles and the effect on wound healing. Surg Clin North Am 83: 509-520.
44. Vercelli S, Ferriero G, Sartorio F et al. 2009: How to assess postsurgical scars: a review of outcome measures, Disabil Rehabil 31: 2055-2063.
45. Yoshikawa T, Mitsuno H, Nonaka I et al. 2008; Wound therapy by marrow mesenchymal cell transplantation. Plast Reconstr Surg 121: 860-877.
46. Zuk PA, Zhu M, Mizuno H et al. 2001; Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211-228.